跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clavmoxwel-156.25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clavmoxwel-156.25
Approved
STANDARD
Clavmoxwel-156.25
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1b0c39003c3d5af2
Company
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)
Type
Standard
Approval Details
Approval Id
1b0c39003c3d5af2
Drug Approval Philippines Name
Clavmoxwel-156.25
Product Name
Clavmoxwel-156.25
Registration Number
DRP-4231
Brand Name
Clavmoxwel-156.25
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Suspension
Dosage Strength
156.25 mg per 5 mL
Manufacturer
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)
Importer
Ambica International Corporation
Distributor
Diafarm, Inc
Issuance Date
25 August 2022
Expiry Date
14 February 2028
Pharmacologic Category
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1b0c39003c3d5af2
Type
Standard
Back to Philippines FDA Approvals